TY - JOUR
T1 - Ischemia-reperfusion injury in sickle cell anemia
T2 - Relationship to acute chest syndrome, endothelial dysfunction, arterial vasculopathy, and inflammatory pain
AU - Hebbel, Robert P.
PY - 2014/4
Y1 - 2014/4
N2 - Ischemia-reperfusion (I/R) physiology, also called reperfusion injury, instigates vascular and tissue injury in human disease states. This review describes why sickle cell anemia should be conceptualized in this fashion and how I/R physiology explains the genesis of characteristic aspects of vascular pathobiology and clinical disease in sickle cell anemia. The nature of I/R and its relevance to sickle cell anemia are discussed, with an emphasis on the acute chest syndrome, endothelial dysfunction with aberrant vasoregulation, circle of Willis vasculopathy, and inflammatory pain. Viewing sickle disease from this perspective elucidates defining pathophysiology and identifies a host of novel potential therapeutic targets.
AB - Ischemia-reperfusion (I/R) physiology, also called reperfusion injury, instigates vascular and tissue injury in human disease states. This review describes why sickle cell anemia should be conceptualized in this fashion and how I/R physiology explains the genesis of characteristic aspects of vascular pathobiology and clinical disease in sickle cell anemia. The nature of I/R and its relevance to sickle cell anemia are discussed, with an emphasis on the acute chest syndrome, endothelial dysfunction with aberrant vasoregulation, circle of Willis vasculopathy, and inflammatory pain. Viewing sickle disease from this perspective elucidates defining pathophysiology and identifies a host of novel potential therapeutic targets.
KW - Endothelial dysfunction
KW - Inflammation
KW - Ischemia-reperfusion
KW - Sickle
UR - http://www.scopus.com/inward/record.url?scp=84896849171&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896849171&partnerID=8YFLogxK
U2 - 10.1016/j.hoc.2013.11.005
DO - 10.1016/j.hoc.2013.11.005
M3 - Review article
C2 - 24589261
AN - SCOPUS:84896849171
SN - 0889-8588
VL - 28
SP - 181
EP - 198
JO - Hematology/Oncology Clinics of North America
JF - Hematology/Oncology Clinics of North America
IS - 2
ER -